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Socioeconomic deprivation and surgical outcomes: 
ISOS and VISION-UK sub-study 
Statistical analysis plan 
 
Investigators 
Wan, McGuckin, Fowler, Prowle, Pearse, Moonesinghe 
 
Working title 
Prospective observational cohort study of socioeconomic deprivation and post-operative 
outcomes following elective surgery within ISOS and VISION-UK. 
 
Background 
Surgery is one of the most common treatments offered by the NHS in secondary care within 
the UK. One in ten adults has a surgical procedure each year, and the annual number of 
procedures is increasing steadily, particularly in elderly patients.1 There are 4.6 million 
hospital admissions that lead to surgical care every year in England alone (Hospital Episode 
Data, Department of Health). One in five people in England aged 75 years and over underwent 
surgery in 2015.2 Perioperative complications present a substantial burden to healthcare cost 
due to associated mortality and morbidity.3-5 
 
The link between poverty, socioeconomic inequalities and increased mortality is well 
established.6 Differences in socioeconomic status have been shown to be associated with 
increased mortality in a range of diseases as well as incidence of multimorbidity.7-11 
Inequalities in healthcare continue to exist globally.12 Improvements in healthcare provision 
in the UK over time such as in cancer care have not been demonstrated across socioeconomic 
groups with persistent limitations in the most deprived areas.13 The reasons for this are 
multifactorial including barriers in accessing healthcare secondary to both financial 
limitations and geographical distance, variations in availability and quality of services in areas 
of greater deprivation, differences in lifestyle factors such as smoking, alcohol and dietary, as 
well as health seeking behaviour.14-18 
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Studies including systematic reviews have demonstrated an association between 
socioeconomic deprivation on mortality and morbidity after specific types of surgery 
including colorectal 19, endometrial cancer20, major elective joint replacement21, head and 
neck cancer22, lung cancer23, amputation in peripheral artery disease24. These observation 
studies have tended to be carried out in single centres, smaller cohorts or for specific disease 
indications. 
 
The office for national statistics have published data measuring relative deprivation in small 
areas in England.9 The English Indices of Deprivation 2015 is a composite score based on 37 
separate indicators. These are grouped into seven distinct domains: income; employment; 
health and disability; education, skills and training; barriers to housing and other services; 
crime; living environment.9 Similarly, Scotland, Northern Ireland and Wales have calculated 
comparative statistical measures.25-27 In this paper, we aim to determine if socioeconomic 
deprivation in England is associated with outcomes after surgery: mortality, in-hospital 
complications at 30 days, and hospital length of stay. We will also identify clinical factors 
associated with social deprivation and assess whether adjustment for these factors modify 
the effect of socioeconomic deprivation on outcomes for a range of surgical categories.  
 
Aim 
To describe the distribution of socioeconomic status amongst the ISOS and VISION-UK cohorts 
undergoing elective surgery and its association with post-operative complications within 30 
days (specific endpoints defined below) and death within 3 years. 
 
Objectives 
1. To describe socioeconomic status of the study population as measured by index 
of multiple deprivation quintiles 
2. To determine if socioeconomic status is associated with the following outcomes: 
- mortality at 30 days, at 1 year, and at 3 years 
- in-hospital complications at 30 days 
- hospital length of stay 
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3. To determine if different surgical categories vary for the following outcomes when 
deprivation is taken into account: 
- mortality at 30 days, at 1 year, and at 3 years 
- 30 day in-hospital mortality 
- hospital length of stay 
 
Data collection 
Study cohorts 
The International Surgical Outcome Study (ISOS) is an international multi-centre cohort study 
of perioperative morbidity and mortality in patients undergoing elective surgery 
(ISRCTN51817007).9 Data collection occurred during a seven-day period between April and 
August 2014 in 474 hospitals in 27 countries. All patients admitted to participating centres for 
elective surgery with a planned overnight stay were eligible. Patients undergoing day-case 
surgery or radiological procedures were excluded because they followed a dedicated pathway 
of care. Only patients from England will be included in this secondary analysis, xx hospitals 
participated in the UK, leading to a sample size of xxx patients. Patients were followed up for 
a maximum of 30 days after surgery for complications. Mortality data is collected up to 3 
years post-operatively. 
 
The Vascular Events in non-cardiac surgery (VISION) study is a prospective, international 
cohort study designed to evaluate major complications following non-cardiac surgery. 
Patients are eligible if they are 45 years or older and receiving either general or regional 
anaesthesia, requiring at least an overnight stay in hospital. The research ethics 
committee/institutional review board at each site approved the protocol prior to patient 
recruitment. For this analysis, only patients from England were included, from 4 sites. 
Detailed and standardised data are collected before surgery, during the patient’s hospital stay 
until discharge, at 30 days, and at one year after surgery. 
 
Sample 
The dataset for this secondary analysis includes only patients from England from both the 
ISOS and VISION-UK cohorts with mortality outcome data. 
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Definition of key variables 
The paper case report forms (CRF) are shown in appendix 1 and 2. Baseline demographics and 
clinical data for patients will be summarised and presented for each socioeconomic quintile 
but not subject to statistical testing. The following baseline characteristics will be compared. 
Numbers (%) or means (SD) and medians (IQR) will be given for each group as appropriate. 
Patient characteristics: Age in years, Sex (M/F), Current smoker (Y/N), ASA (I-IV), 
Comorbidities – Coronary artery disease (Y/N), Diabetes mellitus (Y/N), Metastatic cancer 
(Y/N), COPD/asthma (Y/N), Heart failure (Y/N), Stroke/TIA (Y/N), pre-operative Haemoglobin 
level in g/L, pre-operative Creatinine in µmol/L. 
Surgical factors: Surgical procedure (Orthopaedic/Breast/Obstetrics and 
gynaecology/Urology and kidney/Upper gastro-intestinal/Lower gastro-intestinal/Hepato-
biliary/Vascular/Head and neck/Plastics and cutaneous/Cardiac/Thoracic/Other), Severity of 
surgery (Minor/Intermediate/Major), Laparoscopic surgery (Y/N), Cancer surgery (Y/N) 
 
Statistics on relative measures of socioeconomic deprivations are publicly available according 
to the postcode of the patient’s home address. The English Indices of Deprivation 2015 (IMD 
2015) based on statistics from 2012 to 2013 will be used. The contribution of each of the 
seven distinct domains to the overall score is weighted differently, with income and 
employment deprivation weighted the most, to calculate the Index of Multiple Deprivation 
(IMD). Lower-Layer Super Output Areas (LSOAs) are small areas designed to be of a similar 
population size, with an average of approximately 1,500 residents or 650 households. There 
are 32,844 Lower-layer Super Output Areas (LSOAs) in England which have been divided 
according to their deprivation rank into 10 equal groups (deciles). Analysis will be carried out 
by using quintiles of deprivation for LSOAs ranked by IMD in the combined cohort to account 
for potential disproportionate grouping in different deciles of IMD in our dataset. 
 
Statistical analysis 
The analysis will be conducted in two stages. First, we will examine whether deprivation, 
classified by IMD 2015, is associated with mortality at 30 days, mortality at 1 year, mortality 
at 3 years, in-hospital complications at 30 days, and hospital length of stay. Mortality data to 
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3 years is only available for ISOS and so analysis for this outcome is limited to the ISOS 
cohort. Secondly, we will identify factors which are strongly associated with deprivation (we 
anticipate these might be smoking and diabetes) and assess whether adjustment for these 
factors modify the effect of socioeconomic deprivation on outcomes. 
 
Primary analyses 
The primary outcome is mortality. Univariable and multivariable logistic regression analyses 
will be used to test association between socioeconomic deprivation categorised by IMD 
quintiles and mortality at 30 days, 1 year, and 3 year. The following additional variables will 
be entered into the multivariable model: Age, Sex, Current smoker, ASA, any type of 
Comorbid disease, pre-operative Haemoglobin, pre-operative Creatinine. Results will be 
presented as odds ratios with 95% confidence intervals. Mixed effects logistic regression 
models using a random intercept for hospital site will be repeated for the primary outcome 
and included as a sensitivity analysis. 
 
The secondary outcomes include in-hospital complications at 30 days and hospital length of 
stay. Specific complications include: Surgical site infection, Body cavity infection, 
Pneumonia, Urinary tract infection, Blood stream infection, Myocardial infarction, 
Arrhythmia, Pulmonary oedema, Pulmonary embolism, Stroke, Cardiac arrest, Gastro-
intestinal bleed, Acute kidney injury, Postoperative bleed, Acute Respiratory Distress 
Syndrome, Anastomotic leak. A multivariable logistic regression model will be developed 
using presence of complication as the endpoint and with the same covariates as the primary 
model. Adjusted odds ratios with 95% confidence intervals will be presented in a table with 
the incidence of each type of complication expressed as a percentage. Only patients who 
experience each complication alone will be included to prevent duplication. Sensitivity 
analyses will be carried out for patients who experience more than one complication and for 
patients with complications classified as severe. To test association with hospital length of 
stay and socioeconomic deprivation, a linear regression model will be constructed using the 
same method as above. The endpoint will be hospital length of stay in days. The 
independent variables will be same as the primary model. All models based on mixed effects 
regression modelling with a random intercept for hospital site will be included as a 
sensitivity analysis as per the primary outcome model. 
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Secondary analyses 
The secondary objective of this paper is to identify how mortality and hospital length of stay 
vary for different surgical categories when deprivation is taken into account. For this 
analysis, a Cox proportional hazards model will be constructed with the following 
covariates: Surgical category, Socioeconomic quintile, hospital length of stay with 30 day 
mortality as a competing outcome and any other variables which were found to be 
significantly associated with deprivation in the model above. 
 
Age adjustment 
Differences in age was expected between socioeconomic groups and seen when cohort 
baseline characteristics were examined. As such, all univariable analyses were conducted 
adjusted for age. 
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Figures and tables 
 
Figure 1: STROBE flow diagram of study population 
  
Total ISOS and VISION-UK patients 
(n=) 
 
Excluded: missing mortality 
outcome (n=) 
 
Patients included into sub-study 
(n=) 
Reason for further exclusion (if 
applicable) (n=) 
 
Dataset analysed 
(n=) 
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Figure 2: Socioeconomic deprivation and surgical outcomes by geography. 
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Table 1: Baseline characteristics. All numbers shown in n (%) unless stated otherwise. 
 Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Age 
Mean (SD)      
Median (IQR)      
Male      
Current smoker      
ASA 
1      
2      
3      
4      
Co-morbid disease 
Coronary artery disease      
Diabetes mellitus      
Metastatic cancer      
COPD/asthma      
Heart failure      
Cirrhosis      
Stroke      
Other      
Pre-operative Haemoglobin      
Pre-operative Creatinine      
Surgical procedure      
Orthopaedic      
Breast      
Obstetrics and gynaecology      
Urology and kidney      
Upper gastro-intestinal      
Lower gastro-intestinal      
Hepato-biliary      
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Vascular      
Head and neck      
Plastics and cutaneous      
Cardiac      
Thoracic      
Other      
Severity of surgery 
Minor      
Intermediate      
Major      
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Table 2: Association between deprivation and mortality 
Socioeconomic 
quintile 
Mortality 
(n, %) 
Univariable Multivariable 
Odds ratio (95% CI) P value Odds ratio (95% CI) P value 
30 day mortality   
Quintile 1      
Quintile 2      
Quintile 3      
Quintile 4      
Quintile 5      
1 year mortality   
Quintile 1      
Quintile 2      
Quintile 3      
Quintile 4      
Quintile 5      
3 year mortality    
Quintile 1      
Quintile 2      
Quintile 3      
Quintile 4      
Quintile 5      
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Figure 3: Kaplan-Meier graph of mortality categorised by socioeconomic deprivation 
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Table 3: Association between deprivation and in-hospital complications 
Socioeconomic 
quintile 
In-hospital 
complication 
(n,%) 
Univariable Multivariable 
Odds ratio 
(95% CI) 
P value Odds ratio 
(95% CI) 
P value 
Quintile 1      
Quintile 2      
Quintile 3      
Quintile 4      
Quintile 5      
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Figure 4: Kaplan-Meier graph of in-hospital complications categorised by socioeconomic 
deprivation 
  
 Version 1.2 19/02/2020 
17 
Table 4: Association between deprivation and length of hospital stay 
Socioeconomic 
quintile 
Univariable Multivariable 
Length of hospital stay  
(95% CI) 
P value Length of hospital stay  
(95% CI) 
P value 
Quintile 1     
Quintile 2     
Quintile 3     
Quintile 4     
Quintile 5     
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Table 5: Association between surgical outcomes in different surgical categories (adjusted for deprivation) 
Surgical procedure Incidence of 
complication 
(n, %) 
In-hospital mortality In-hospital complication 
Unadjusted odds ratio 
(95% CI) 
Adjusted* odds ratio 
(95% CI)  
Unadjusted odds ratio 
(95% CI) 
Adjusted* odds ratio 
(95% CI)  
Orthopaedic      
Breast      
Obstetrics and gynaecology      
Urology and kidney      
Upper gastro-intestinal      
Lower gastro-intestinal      
Hepato-biliary      
Vascular      
Head and neck      
Plastics and cutaneous      
Cardiac      
Thoracic      
Other      
*adjusted for socioeconomic quintiles 
 
 Version 1.2 19/02/2020 
19 
Appendix 1 CRF for ISOS 
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Appendix 2 CRF for VISION 
 
 
VISION #019
PATIENT
Centre No. Patient No.
PATIENT 
F     M     LID: INITIALS:
VISION
  
                                                                                                                           Pregnancies with 
                                                                                                                      Severe Pre-Eclampsia 
            Pregnancies with
Plate #001 Visit #000
1.   Patient is  > 45 years of age, has had noncardiac surgery requiring overnight hospital 
2.   Patient consents prior to or within the first 24hrs after surgery to participate in the 
1. Date of Birth
year  month  day
PREOPERATIVE  ASSESSMENT (see back for definitions)
ELIGIBILITY AND PRE-OPERATIVE ASSESSMENT FORM 1.1
2.  Male
Female
      admission and has received a general or regional anaesthetic.                 
3.   Patient previously enrolled in VISION.
Answers must be “yes” to question 1 & 2 and “no” to question 3 to be eligible for enrollment.
   
15. History of cardiac catheterization/revascularization? 
CABG
date of most recent procedure
year
PCI Stent No
Yes DES
17.  Does the patient have known aortic stenosis?  
No Yes
No Yes
No Yes
      VISION study including the 30 day and 1 year followup.
Person completing _________________   ________
form  (please print)          Last Name                   First Initial 
    _________________    ____________________
       Investigator’s Name                   Investigator’s Signature     VERSION 8 - FEB 6, 2009 
   
8.  Prior to hospitalization how many hours per day on average was patient bedridden?  
7.  Patient requires assistance with ADL  
kg
lbs
3.  Weight
cm
in
Code # 
4.  Height
6.  Is the patient living in a nursing home? 
5. Ethnicity:
9.  History of tobacco use? 
Avg # per day of all
Year started Date of last use prior to surgery
Cigarettes
Cigars Pipes
tobacco products 
Chewing tobaccoPaan
Snuff Sheesha/water pipe
Type of tobacco use
(check all that apply)
Beedies
No Yes
 month  day year 
18.  History of DVT/PE ?
PE
DVT
date of most recent event
 year   month
No Yes
16. History of cardiac arrest?
   
date of most recent event
 year   month
14.  History of recent (i.e., < 6 months) high-risk coronary artery disease? 
year  month  day
myocardial infarction
acute coronarysyndrome
CCSC III
CCSC IV
19.  History of cerebral vascular event?
TIA
Strokedate of most recent event
year  month
No Yes
25.  History of diabetes?
   year of diagnosis
13. History of coronary artery disease? 12.  History of congestive heart failure?
10.  Currently in atrial fibrillation? 
No Yes
No Yes No Yes
20.  History of obstructive sleep apnea?
24.  History of COPD ?
22.  History of hypertension?
21.  History of peripheral vascular disease? No Yes
No Yes
No Yes
No Yes No Yes
No Yes
11. Not currently in atrial fibrillation, but prior history of atrial fibrillation? 
23.  History of peptic ulcer disease in the previous 6 months? No Yes
No Yes
No Yes
 month
No Yes
b. > 12 months prior to surgery?
No Yes Cardiac Cath only
No
Yes
a. < 12 months prior to surgery? If Yes. please complete Pre-op Cardiac Cath/Revasc Form 6.1
check most 
recent event
No Yes No Yes
No Yes please complete Aortic Stenosis Form 7.1 
Date form
completed year               month         day         
26.  Surgery performed:
< 24hrs since acute event  
that led to need for surgery
24-72hrs since acute event all other
surgeriesthat led to need for surgery
2  0
27.  For FEMALEs, number of pregnancies
                                                                                                                                                Pre-Eclampsia                          
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VISION #019
PATIENT
Centre No. Patient No.
PATIENT 
F     M     LID: INITIALS:
VISION
  
X
       Lowest value  
        of  Longest 
  Hypotensive Event
  Start date of Longest
   Hypotensive Event
Plate #002 Visit #000
       PREOPERATIVE / HAEMODYNAMICS                                FORM 1.2
3.  Systolic Blood Pressure > 160 mmHg 
PREOPERATIVE  ASSESSMENT (continued)
No Yes
1.  Does the patient have “active” cancer?
date of fracture
  month  day
Lowest   Duration (min)
PACU
HAEMODYNAMICS:
2.  Systolic Blood Pressure < 100 mmHg 
Intraop
           VERSION 3 - Apr 22, 2009
Person completing _________________   ________
form (please print)          Last Name          First Initial 
 _________________    ____________________
Investigator’s Name      Investigator’s Signature 
 Duration (min)
  value 
5.  Heart Rate  > 100 bpm 4.  Heart Rate   <  55 bpm 
type of 
fracture
see back90 - 99 mmHg
        
        
< 90 mmHg
Rx code
No Yes
Highest   Duration (min)
       Duration (min)  value > 200 mmHg161 - 199 mmHg
No Yes
  Duration (min)
      
 Duration (min)  Lowest 
see back45 - 54 bpm< 45 bpm
Rx code    Duration (min)  Duration (min)
a.  Blood pressure 
systolic diastolic
mmHg b. Heart rate bpm
g/dL
  b. Hemoglobin level
Time 
Period
OR day 
post PACU
POD 1
POD 2
POD 3
POD 4 to
discharge
PACU
Intraop
  Time 
Period
OR day 
post PACU
POD 1
POD 2
POD 3 to 
6.  Is patient on dialysis?
. umol/Lmg/dL
4.  Is the patient’s surgery for an acute fracture?
a. NT-proBNP
7.  Preoperative laboratory tests:  
pg/ml
pmol/L
.
No Yes
mmol/L
mg/dL
  d. Glucose level measured 
.c. Most recent Creatinine
g/L
No Yes
No Yes
not
measured
not
measured
not measured
No Yes
IV dextrose/TPN running or active enteral Yes
No
# hrs since p.o. or
any enteral intake
lab
finger-stick
1.  Record pre-op vital signs measurements that are closest and prior to anesthesia induction
                        
                        
No Yes
Highest
  value > 140 bpm101 - 140 bpm
        
discharge
6.  Respiratory  
    Rate < 10/min 
POD 0-4 Lowest value   Duration (min) 7.  Oximetry  
< 90% No Yes
Rx code POD 0-4 Lowest value   Duration (min) No Yes Rx code
Date form
completed year               month         day         
feeds at time of glucose measurement?
2  0
Code #3.  Does patient have metastatic disease? No Yes
5.  History of chronic pain? No Yes
(see back)
2.  Is the patient’s surgery  for cancer? No Yes
 
        
2  0
   Value 
       Lowest value  
        of  Longest 
  Bradycardia Event
Start date of  Longest
   Bradycardia Event 2  0
year                        month              day
year                       month             day
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VISION #019
PATIENT
Centre No. Patient No.
PATIENT 
F     M     LID: INITIALS:
VISION
  
Plate #005 Visit #001
PREOPERATIVE CARDIAC MEDICATIONS 
INTRAOPERATIVE AND POSTOPERATIVE ASSESSMENT
OPERATIVE ASSESSMENT FORM 2.1
TYPE OF SURGERY PERFORMED   
thoracic aorta reconstruction
   aorto-iliac reconstruction
   peripheral vascular reconstruction
without aortic cross-clamping
extracranial cerebrovascular surgery
lower leg amputation
partial or  total colectomy, or   
stomach surgery
other intra-abdominal surgery
major head and neck resection for 
                                                              
complex visceral resection                        
EVAR
1.
Major Orthopedic Surgery
major hip or pelvic surgery
internal fixation of femur
low risk surgeries 
knee arthroplasty
Other Surgeries
transurethral prostatectomy
Major Urology or Gynecology
  visceral resection
cytoreductive surgery
radical prostatectomy
radical hysterectomy
 other thoracic surgery
Thoracic Surgery
pneumonectomy
lobectomy
hysterectomy
 
Date form
completed year               month         day         
Person completing ____________________   ________
form (please print)             Last Name            First Initial  
_________________________ _________________________
      Investigator’s Name                   Investigator’s Signature 
 VERSION 7- June 10, 2008
 
 
Indicate any use during the following periods prior to surgery:
    (check all that apply)  (see back for definitions)
Vascular Surgery 
  General Surgery 
above knee amputation
< 24 hrs       > 24 hrs to 7 days   
 < 24 hrs 
major spine surgery
craniotomy
Major Neurosurgery
cessation drugs 
 5. Date of surgery
6. Time of surgery
 
year month day
    generalspinal
nerve block
epidural lumbar 
Surgical technique:  2.
year month day
8. Type of anaesthetic
 7. Did patient receive any of the following post surgery?
 Endoscopic    Open     3. Was surgery reported as minimally invasive? No Yes
       (check all that apply)
# days
c. Epidural Opioid Analgesia
d. Epidural Local Analgesia 
a. Patient Controlled Analgesia 
b. Continuous Nerve Block
if yesNo Yes
thoracic 
No
Yes
Local anaesthetic 
(check all that apply)
: :Start End
24 hr clock24 hr clock
e. Topical/IM/IV/SC opioids nitrous oxide
non-thyroid tumor
2  0
             >24 hrs to 7 days  
 
       1. Aspirin 12. NSAID/
4. Long-acting nitrate
5. Oral Anticoagulant
 
6. ACEI/ARB
               
7. Beta-blocker
16. Prophylactic subc 
     antithrombotic agent
   15. Dihydropyridine CCB
   
                                                                    
14. Rate Controlling CCB
  non-COX-2 Inhibitor 
11. COX-2 Inhibitor 
  
13. Alpha 2 agonist
8. Non-statin choleste- 
   rol lowering drug
9. Statin 
17. Therapeutic subc or IV
      antithrombotic agent
3. Oral diabetic drug
18. Nicotine Replacement 
19. Non-nicotine smoking
2. Insulin 
10. Ticlopidine or Plavix
No       Yes
No        Yes
No       Yes
No        Yes
in epidural
4. Date of hospitaladmission
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VISION #019
PATIENT
Centre No. Patient No.
PATIENT 
F     M     LID: INITIALS:
VISION
  
Plate #010 Visit #002
POSTOPERATIVE  TROPONIN  T  or  TROPONIN T hs RESULTS (see back      ) specify 
 
HOSPITAL DISCHARGE (see back for explanation)
1. Date of discharge 
year               month         day
3. Number of nights
FORM 3.1DISCHARGE ASSESSMENT
CLINICAL EVENTS DURING HOSPITALIZATION
8. Sepsis/Infection
9. Pneumonia 
 
10. New clinically important 
        
atrial fibrillation
11. Congestive heart failure 
   
     
 
Person completing   ____________________   ________
form (please print)                Last Name              First Initial  
_________________________ _________________________
      Investigator’s Name                   Investigator’s Signature 
VERSION 7 - Apr 26, 2010
Year Month Day
:
24 hour clock
.
On Day 1 post-op
TnT hs (5th generation)
: .
: .
: .
6 - 12 hours post-op1.
2.
On Day 2 post-op3.
On Day 3 post-op4.
 
    <  check if 
Any use during 
At discharge
At discharge
MEDICATIONS IN HOSPITAL
   
       
   
in ICU/CCU2. Was patient 
 another facility?
No
    
 
Yes 
transferred to
Complete Patient Transfer Form 8.1
Death
Myocardial 
Non-fatal 
Stroke
No Yes
1.
2.
3.
4.
 
;
;
;
cardiac arrest
New acute 7.
(requiring dialysis)
0  0  
0  3  
4  4  
Leg or arm 
Bleeding
5.
6.
;
;
5  
6  
5  
6  
Infarction
No Yes ;
;
8  8  
9  9  
;
;
1  
1  
1  
1  1  1  
0  0  
20. Naloxone (see back)
 
renal failure 
;7  7  
12. Cardiac catheterization ; 1  1  2  2  
 
13. PCI ; 1  1  3  3  
 14. CABG ; 1  1  4  4  
 If Yes, complete Report Number (s) 
 
2  2  
3  0  
0  
0  
0  
0  
0  
0  
0  
0  
0  
0  0  
0  
If Yes, complete Report Number (s)  
0  1  0  
1. Aspirin 12. NSAID/
4. Long-acting nitrate
5. Oral Anticoagulant
 
6. ACEI/ARB
               
7. Beta-blocker
16. Prophylactic subc 
     antithrombotic agent
   15. Dihydropyridine CCB
   
                                                                    
14. Rate Controlling CCB
  non-COX-2 Inhibitor 
11. COX-2 Inhibitor 
  
13. Alpha 2 agonist
8. Non-statin choleste- 
   rol lowering drug
9. Statin 
17. Therapeutic subc or IV
      antithrombotic agent
3. Oral diabetic drug
18. Nicotine Replacement 
19. Non-nicotine smoking
cessation drugs 
2. Insulin 
Date form
completed year               month         day         
10. Ticlopidine or Plavix
 15. Amputation (see back) ; 1  1  5  5  
include events already reported on 30 Day Follow up Form 4.1)  
DVT/PE
2  0
2  0
first 3 days post op 
Any use during 
first 3 days post op 
If patient is discharged after 30 day follow up do not
No       Yes
No        Yes
No       Yes
No        Yes
X ng/L
    or other injectables
  ug/L  TnT       (4th generation)
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VISION #019
PATIENT
Centre No. Patient No.
PATIENT 
F     M     LID: INITIALS:
VISION
  
Plate #020 Visit #003
1.  30 day post-op date
year                            month                day
5.  Has the patient been rehospitalized since discharge?
No Yes Date
year                            month              day
FORM 4.130 DAY FOLLOW-UP
 
Was admission for vascular reasons?
No Yes
     
(see definition on back)
Person completing ____________________   ________
form (please print)             Last Name            First Initial  
_________________________ _________________________
      Investigator’s Name                   Investigator’s Signature 
VERSION 5 -Feb 24, 2009
MEDICATIONS AT 30 DAY FOLLOW UP
CLINICAL EVENTS UP TO 30 DAYS AFTER SURGERY  
(Do not include events already reported on Discharge Form 3.1)  
No       Yes
g/L
g/dL
Avg # per day of all
Date started after surgery
Cigarettes
Cigars Pipes
tobacco products 
Chewing tobaccoPaan
Snuff Sheesha/water pipe
Type of tobacco use
(check all that apply)
Beedies
No Yes
 month  day year 
   CURRENT TOBACCO USE 
3.  Is patient living in a nursing home? YesNo
  b. Lowest Hemoglobin level
2.  Was the 30 day follow up completed? NoYes Reason:
.
umol/L
mg/dL
  a. Highest serum creatinine level
not measured
not measured
   4. From date of surgery up to 30 days postop, complete:
Date form
completed year               month         day         
     
1. Aspirin 
4. Long-acting nitrate
5. Oral Anticoagulant
 
6. ACEI/ARB
               
7. Beta-blocker
  
2. Insulin
8. Non-statin cholesterol 
   lowering drug
10. Ticlopidine or Plavix
9. Statin 
12. NSAID/
16. Prophylactic subc 
     antithrombotic agent
   15. Dihydropyridine CCB
 non-COX-2 Inhibitor 
14. Rate Controlling CCB
11. COX-2 Inhibitor 
13. Alpha 2 agonist
17. Therapeutic subc or IV
      antithrombotic agent
No     Yes
18. Nicotine Replacement 
No       Yes
19. Non-nicotine smoking
cessation drugs 
3. Oral diabetic drugs
 
  c. RBCs transfused
   # total units
8. Sepsis/Infection
9. Pneumonia 
 
10. New clinically important 
        
atrial fibrillation
11. Congestive heart failure  
Death
Myocardial 
Non-fatal 
Stroke
No Yes
1.
2.
3.
4.
;
;
;
cardiac arrest
0  0  
0  3  
4  4  
Leg or arm 
Bleeding
5.
6.
;
;
5  
6  
5  
6  
Infarction
No Yes ;
;
8  8  
9  9  
;
;
1  
1  
1  
1  1  1  
0  0  
12. Cardiac catheterization ; 1  1  2  2  
 
13. PCI ; 1  1  3  3  
14. CABG ; 1  1  4  4  
 If Yes, complete Report Number (s) 
2  2  
3  0  
0  
0  
0  
0  
0  
0  
0  
0  0  
0  
If Yes, complete Report Number (s)  
0  1  0  
15. Amputation ; 1  1  5  5  
DVT/PE
2  0
2  0
  
New acute 7.
(requiring dialysis)
renal failure 
;7  7  0  0  
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VISION #019
PATIENT
Centre No. Patient No.
PATIENT 
F     M     LID: INITIALS:
VISION
  
Version 9: 2012 Jun 01
  
Plate #025 Visit #004
1.   1 year post-operative date:
year                    month          day
2.   Was the 1 year follow-up completed? Yes No Reason:
4.   
No Yes Date
year                    month          day
FORM 5.1ONE YEAR FOLLOW-UP
If Yes, was admission for vascular reasons? No Yes
   
Has the patient been rehospitalized between the 30 day and 1 year follow-up?
CLINICAL EVENTS BETWEEN 30 DAYS AND ONE YEAR FOLLOW-UP
MEDICATIONS AT ONE YEAR FOLLOW UP
   CURRENT TOBACCO USE 
Avg # per day of all
Date started after surgery
Cigarettes
Cigars Pipes
tobacco products 
Chewing tobaccoPaan
Snuff Sheesha/water pipe
Type of tobacco use
(check all that apply)
Beedies
No Yes
 month  day year 
# days in hospital
    
12.   New diagnosis of diabetes since surgery  
No  Yes
6.  Is patient on dialysis? No Yes
3.  Is patient living in a nursing home? Yes No
8.  Cardiac catheterization ; 1  1  2  2  
 
9.  PCI ; 1  1  3  3  
 10. CABG ; 1  1  4  4  
Myocardial 
Non-fatal 
Stroke
2.
3.
4.
;
;
;
cardiac arrest
0  0  
0  0  
0  0  
Leg or arm5. ;0  0  
Infarction
2  2  
3  3  
4  4  
5  5  
Death
No Yes
1.
If Yes, complete Report Number (s)  
0  1  0  
7.  Congestive heart failure ; 1  1  1  1  
     
Date form
completed year               month         day         
1. Aspirin 
4. Long-acting nitrate
5. Oral Anticoagulant
 
6. ACEI/ARB
               
7. Beta-blocker
  
2. Insulin
8. Non-statin cholesterol 
   lowering drug
10. Ticlopidine or Plavix
9. Statin 
12. NSAID/
16. Prophylactic subc 
     antithrombotic agent
   15. Dihydropyridine CCB
 non-COX-2 Inhibitor 
14. Rate Controlling CCB
11. COX-2 Inhibitor 
13. Alpha 2 agonist
17. Therapeutic subc or IV
      antithrombotic agent
No     Yes
18. Nicotine Replacement 
No       Yes
19. Non-nicotine smoking
cessation drugs 
3. Oral diabetic drugs
No       Yes
DVT/PE  11.  Amputation ; 1  1  5  5   
2  0
2  0
13.    New diagnosis of cancer since surgery  
14.    Diagnosis of recurrent cancer since surgery     year 
  
              year                      month                day
  
15.    New diagnosis of dementia since surgery
Person completing           __________         ____
form (please print)        Last Name     First Initial  _________                   _____________      Investigator’s                                Investigator’sVERSION 6 -October 9, 2009           Name                                            Signature     
    or other injectable
  
 16.   Incisional site pain  Complete Chronic Pain
Form 5.2 
